The Fast Pace of Biotech The biopharmaceutical industry has embraced the adage of “Don’t be afraid of change, welcome it.” In doing so, the industry has fuelled a st...

In this white paper, Broughton summarises the ‘historical’ development plan for pharmaceuticals, the changes that have occurred with regards to differential developme...

Biologics are a broad class of therapeutic agents, encompassing vaccines, monoclonal antibodies, therapeutic proteins, nucleic acid-based therapies, blood components,...

Developing a drug can take years and comes with significant costs. During the early phases of this journey, it is vital to have a robust process in place to allow rap...

Optimised development and manufacturing processes that accelerate biologic production timelines while keeping costs down are critical to meeting the market demand. St...

  Åsa Bergström, Director of Sustainability, Recipharm explores how pharmaceutical companies can address challenges to making a meaningful contribution to globa...

Gene-modified cell therapy for the treatment of cancer and other diseases is a rapidly growing area of clinical research. The therapeutic use of engineered cells has ...

The Model T Ford is still discussed in business schools today because of how Henry Ford relentlessly drove quality and innovation. When first introduced in 1908 the M...